2019
DOI: 10.1590/1678-4324-2019180766
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Oral Oxytetracycline-Therapy on Wound Progression and Healing Following Aeromonas caviae Infection in Nile Tilapia (Oreochromis niloticus L.)

Abstract: Effect of oral OTC-therapy against Aeromonas caviae infection by two challenge routes in Nile tilapia are presented • The intramuscular challenge effected high mortalities than abrasion-immersion challenge • The results demonstrated the positive effect of oral OTC-therapy in overcoming the Aeromonas caviae challenge and improving wound healing. • The extent of damage in untreated Nile tilapia lasted longer in both challenge routes 2 Roy, A.; et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…Oxytetracycline is a natural broad-spectrum antibiotic extensively used in global aquaculture due to its limited side effects in the host and broad-spectrum activity against both Gram-negative and Gram-positive bacteria, through the inhibition of protein syn-thesis [11][12][13]. In tilapia, OTC has been shown to successfully treat a range of bacterial diseases including Francisellosis, motile Aeromonas septicemia, and Streptococcosis, which are significant disease challenges for this sector [14][15][16]. Across the global aquaculture industry, OTC is often administered orally in the diet during disease outbreaks, where doses range 50 to 250 mg/kg/day for typically between four and eight days, up to 21 days, depending on the fish species and farming country [17,18].…”
Section: Introductionmentioning
confidence: 99%
“…Oxytetracycline is a natural broad-spectrum antibiotic extensively used in global aquaculture due to its limited side effects in the host and broad-spectrum activity against both Gram-negative and Gram-positive bacteria, through the inhibition of protein syn-thesis [11][12][13]. In tilapia, OTC has been shown to successfully treat a range of bacterial diseases including Francisellosis, motile Aeromonas septicemia, and Streptococcosis, which are significant disease challenges for this sector [14][15][16]. Across the global aquaculture industry, OTC is often administered orally in the diet during disease outbreaks, where doses range 50 to 250 mg/kg/day for typically between four and eight days, up to 21 days, depending on the fish species and farming country [17,18].…”
Section: Introductionmentioning
confidence: 99%
“…Monogeneans cause several problems in freshwater fish culture in Brazil, whether to produce animal protein or for ornamental purposes (Mota Vicente et al, 2021;Steckert et al, 2021). Therapeutic baths are widely used for the prevention and/ or treatment of diseases in fish culture, including salt, formalin, and essential oils (Hashimoto et al, 2016;García-Magaña et al, 2019;Roy et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…Oral administration of Oxytetracycline and Sulfadimethoxine/Ormetoprim was recommended for MAS treatment 107,108 . In recent studies, Oxytetracycline and Ciprofloxacin were applied orally to treat A. hydrophila , A. caviae in Nile tilapia and common carp, C. carpio 109–112 . Ciprofloxacin and Streptomycin are also used to treat A. hydrophila and A. sobria in the farming of black tiger shrimp, Penaeus monodon .…”
Section: Overview Of Motile Aeromonas Infections In Fish Aquaculturementioning
confidence: 99%